Lung cancer immunotherapy biomarkers: refine not reject
- PMID: 29699819
- DOI: 10.1016/S2213-2600(18)30180-2
Lung cancer immunotherapy biomarkers: refine not reject
Comment on
-
Diagnosis and management of pulmonary toxicity associated with cancer immunotherapy.Lancet Respir Med. 2018 Jun;6(6):472-478. doi: 10.1016/S2213-2600(18)30172-3. Lancet Respir Med. 2018. PMID: 29856320 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
